CEACAM6 promotes tumor angiogenesis and vasculogenic mimicry in gastric cancer via FAK signaling
Mingde Zang(Fudan University Shanghai Cancer Center), Min Yan(Zhengzhou University), Zhiyuan Fan(Shanghai First Maternity and Infant Hospital), Hexiao Wang(Memorial Sloan Kettering Cancer Center), Zhenggang Zhu(Wuhan Center for Disease Control and Prevention), Yunqiang Zhang(Shanghai Jiao Tong University), Baogui Zhang(China Agricultural University), Chao Yan(Shanghai Jiao Tong University), Bingya Liu(Shanghai Jiao Tong University), Liping Su(Guangdong Provincial People's Hospital), Chen Li(Shanghai Jiao Tong University), Lei Hu(Anhui Medical University), Jianfang Li(Shanghai Jiao Tong University), Qinlong Gu(Shanghai Jiao Tong University)
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
February 19, 2015
Cited by 64
Related Papers
Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer
|Annals of Oncology|2021|743
IL-6 secreted by cancer-associated fibroblasts promotes epithelial-mesenchymal transition and metastasis of gastric cancer via JAK2/STAT3 signaling pathway
|Oncotarget|2017|400
miR-126 functions as a tumour suppressor in human gastric cancer
|Cancer Letters|2010|298
CD36 mediates palmitate acid-induced metastasis of gastric cancer via AKT/GSK-3β/β-catenin pathway
|Journal of Experimental & Clinical Cancer Research|2019|231
Tumor heterogeneity of gastric cancer: From the perspective of tumor-initiating cell
|World Journal of Gastroenterology|2018|212